Author:
Whitehead William E.,Palsson Olafur S.,Levy Rona L.,Feld Andrew D.,VonKorff Michael,Turner Marsha
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Gastroenterology,Hepatology
Reference33 articles.
1. 1. SJOV VanZanten, NJ Talley, P Bytzer, DA Drossman, E Corazziari, NJ Talley, WG Thompson, and WE Whitehead . Design of treatment trials for the functional gastrointestinal disorders . In: eds., 2nd Ed. McLean, VA: Degnon Associates, 2000 :577 -622 .
2. Adequate Relief as an Endpoint in Clinical Trials in Irritable Bowel Syndrome
3. An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
4. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3
receptor antagonist
5. A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome